Please use this identifier to cite or link to this item:
https://hdl.handle.net/1889/771
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | Gherli, Tiziano | - |
dc.contributor.author | Budillon, Alessandro Maria | - |
dc.date.accessioned | 2008-06-03T08:13:21Z | - |
dc.date.available | 2008-06-03T08:13:21Z | - |
dc.date.issued | 2008-04-16 | - |
dc.identifier.uri | http://hdl.handle.net/1889/771 | - |
dc.description.abstract | Vascular cells have been successfully utilized for tissue engineering in human cardiovascular structures, such as heart valves. The present study evaluates saphenous vein-derived myofibroblasts as an alternative, easy-to-access cell source for human cardiovascular tissue engineering. Immunohistochemistry was performed to characterize cell phenotipe. In conclusion, saphenous vein myofibroblasts cultured,showed excellent in vitro tissue generation. Therefore, the easy-to-access vein cells represent a promising alternative cell source for cardiovascular tissue engineering. | en |
dc.language.iso | Italiano | en |
dc.publisher | Università degli Studi di Parma, Dipartimento di Scienze Chirurgiche | en |
dc.relation.ispartofseries | Dottorato di ricerca in Cardiochirurgia - Tissue engineering nella valvole cardiache biologiche | en |
dc.rights | © Alessandro Maria Budillon, 2008 | en |
dc.subject | Tissue engineering | en |
dc.subject | Cells | en |
dc.subject | Saphenous vein | en |
dc.subject | Valves | en |
dc.title | Ingegneria tissutale come nuovo approccio al trattamento delle patologie valvolari cardiache | en |
dc.type | Doctoral thesis | en |
dc.subject.miur | MED/23 | en |
dc.description.fulltext | open | en |
Appears in Collections: | Scienze chirurgiche. Tesi di dottorato |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Ingegneria tussutale come nuovo approccio al trattamento delle patologie valvolari cardiache.pdf | Tesi dottorato di ricerca | 908.31 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.